
Susan M Domchek MD
Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology
Basser Professor of Medicine, University Pennsylvania
Join to View Full Profile
3400 Spruce St# 15Philadelphia, PA 19104
Phone+1 215-662-3914
Dr. Domchek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1998
- Harvard Medical SchoolClass of 1995
Certifications & Licensure
- NY State Medical License 2024 - 2026
- PA State Medical License 2001 - 2026
- NJ State Medical License 2022 - 2025
- NC State Medical License 2020 - 2022
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- Philadelphia Magazine Castle Connolly, 2011-2013
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2004 Feb 01
- Tamoxifen-MRI Study Start of enrollment: 2000 Sep 01
- Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer.Kaitlin Demarest, Arravinth Anantharajah, Kara N Maxwell, Mersedeh Rohanizadegan, Angela Bradbury
JAMA Network Open. 2025-02-03 - 1 citationsIntegration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma.Kelsey S Lau-Min, Heather Symecko, Kelsey Spielman, Derek Mann, Ryan Hood
JCO Oncology Practice. 2025-02-01 - Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations inand.Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, Mary Beth Terry, James A Chamberlain
Journal of Clinical Oncology. 2025-02-01
Journal Articles
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization StudySusan M Domchek, Wendy K Chung, Patricia A Ganz, Robert L Nussbaum, Journal of the National Cancer Institute
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskPatricia A Ganz, Amanda E Toland, Susan M Domchek, Tanja Pejovic, Clinical Cancer Research
- Ethical Implications of Direct-to-Consumer Hereditary Cancer TestsSusan Domchek, MD, JAMA
- Join now to see all
Press Mentions
- Four Penn Cancer Researchers Inducted as Fellows of the AACR AcademyMarch 10th, 2025
- Clinical Trials Are Testing Ways to Prevent Breast CancerJanuary 15th, 2025
- New Tool Puts Reproductive Risk for BRCA Carriers into PerspectiveDecember 31st, 2024
- Join now to see all
Grant Support
- University Of Pennsylvania Cancer Genetics NetworkNational Cancer Institute2002–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: